Search Results

1 - 2 of 2 items :

  • "pasireotide" x
Clear All
Infertility as the onset of Cushing’s disease: is pasireotide a treatment option?

treatment of Cushing’s disease: a focus on pasireotide. Research and Reports in Endocrine Disorders. 3,31-38. 5. Aron, D.C., Schnall, A.M. & Sheeler, L.R. Cushing’s syndrome and pregnancy. Am J Obstetrics and gynecology, 162 (1),244-252. 6. Ursula, B. (2012). Hyperprolactinemia and infertility: new insight. J Clin Invest. 122 (10), 3791-3795. 7. Gadelha, M.R., Viera Neto, L. (2014). Efficacy of medical treatment in Cushing’s disease: a systeamtic review, Clin Endocrinol (Oxf). 80 (1):1-12 8. Bertagna, X

Open access
Severe hepatocytolisis syndrome - a challenge in medical therapy of Cushing’s disease

References 1. Pivonello, R., De Martino, M. C., De Leo, M., Lombardi, G., & Colao, A. (2008). Cushing’s Syndrome. Endocrinol Metab Clin North Am. 37(1), 135-149, ix. doi: 10.1016/j. ecl.2007.10.010 2. Newell-Price, J., Bertagna, X., Grossman, A. B., & Nieman, L. K. (2006). Cushing’s syndrome. Lancet. 367(9522), 1605-1617. doi: 10.1016/ s0140-6736(06)68699-6 3. Poullot, A-G & Chevalier, N. (2013).New options in the treatment of Cushing’s disease: a focus on pasireotide. Research and Reports in Endocrine Disorders

Open access